Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Arcutis Biotherapeutics (ARQT) Return on Sales (2022 - 2025)

Arcutis Biotherapeutics (ARQT) has 4 years of Return on Sales data on record, last reported at 0.13% in Q4 2025.

  • For Q4 2025, Return on Sales rose 29.0% year-over-year to 0.13%; the TTM value through Dec 2025 reached 0.04%, up 80.0%, while the annual FY2025 figure was 0.04%, 80.0% up from the prior year.
  • Return on Sales reached 0.13% in Q4 2025 per ARQT's latest filing, up from 0.07% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.13% in Q4 2025 and bottomed at 151.24% in Q3 2022.
  • Average Return on Sales over 4 years is 16.46%, with a median of 1.57% recorded in 2023.
  • Peak YoY movement for Return on Sales: surged 14974bps in 2023, then grew 29bps in 2025.
  • A 4-year view of Return on Sales shows it stood at 24.32% in 2022, then soared by 80bps to 4.9% in 2023, then surged by 97bps to 0.15% in 2024, then surged by 185bps to 0.13% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Sales were 0.13% in Q4 2025, 0.07% in Q3 2025, and 0.19% in Q2 2025.